Logo image of OSUR

ORASURE TECHNOLOGIES INC (OSUR) Stock Fundamental Analysis

NASDAQ:OSUR - Nasdaq - US68554V1089 - Common Stock - Currency: USD

2.95  +0.02 (+0.68%)

After market: 2.95 0 (0%)

Fundamental Rating

2

Taking everything into account, OSUR scores 2 out of 10 in our fundamental rating. OSUR was compared to 187 industry peers in the Health Care Equipment & Supplies industry. While OSUR seems to be doing ok healthwise, there are quite some concerns on its profitability. OSUR does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year OSUR has reported negative net income.
OSUR had a positive operating cash flow in the past year.
In the past 5 years OSUR reported 4 times negative net income.
The reported operating cash flow has been mixed in the past 5 years: OSUR reported negative operating cash flow in multiple years.
OSUR Yearly Net Income VS EBIT VS OCF VS FCFOSUR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M -100M

1.2 Ratios

Looking at the Return On Assets, with a value of -6.98%, OSUR is in the better half of the industry, outperforming 65.24% of the companies in the same industry.
With a decent Return On Equity value of -8.06%, OSUR is doing good in the industry, outperforming 67.91% of the companies in the same industry.
Industry RankSector Rank
ROA -6.98%
ROE -8.06%
ROIC N/A
ROA(3y)1.01%
ROA(5y)-1.05%
ROE(3y)0.93%
ROE(5y)-1.4%
ROIC(3y)N/A
ROIC(5y)N/A
OSUR Yearly ROA, ROE, ROICOSUR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10

1.3 Margins

Looking at the Gross Margin, with a value of 41.98%, OSUR is doing worse than 65.24% of the companies in the same industry.
OSUR's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for OSUR so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 41.98%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.22%
GM growth 5Y-6.88%
OSUR Yearly Profit, Operating, Gross MarginsOSUR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

More info and screens

5

2. Health

2.1 Basic Checks

OSUR does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, OSUR has more shares outstanding
OSUR has more shares outstanding than it did 5 years ago.
OSUR has a better debt/assets ratio than last year.
OSUR Yearly Shares OutstandingOSUR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
OSUR Yearly Total Debt VS Total AssetsOSUR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.2 Solvency

An Altman-Z score of 2.63 indicates that OSUR is not a great score, but indicates only limited risk for bankruptcy at the moment.
The Altman-Z score of OSUR (2.63) is better than 65.78% of its industry peers.
OSUR has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
OSUR has a Debt to Equity ratio of 0.00. This is in the better half of the industry: OSUR outperforms 71.12% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 2.63
ROIC/WACCN/A
WACC9.04%
OSUR Yearly LT Debt VS Equity VS FCFOSUR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M 300M 400M

2.3 Liquidity

OSUR has a Current Ratio of 12.34. This indicates that OSUR is financially healthy and has no problem in meeting its short term obligations.
OSUR's Current ratio of 12.34 is amongst the best of the industry. OSUR outperforms 94.12% of its industry peers.
OSUR has a Quick Ratio of 10.94. This indicates that OSUR is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of OSUR (10.94) is better than 94.12% of its industry peers.
Industry RankSector Rank
Current Ratio 12.34
Quick Ratio 10.94
OSUR Yearly Current Assets VS Current LiabilitesOSUR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

More info and screens

2

3. Growth

3.1 Past

OSUR shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -191.30%.
The Revenue for OSUR has decreased by -46.94% in the past year. This is quite bad
OSUR shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.75% yearly.
EPS 1Y (TTM)-191.3%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-320%
Revenue 1Y (TTM)-46.94%
Revenue growth 3Y-7.36%
Revenue growth 5Y3.75%
Sales Q2Q%-44.71%

3.2 Future

The Earnings Per Share is expected to grow by 29.63% on average over the next years. This is a very strong growth
Based on estimates for the next years, OSUR will show a decrease in Revenue. The Revenue will decrease by -3.71% on average per year.
EPS Next Y-123.62%
EPS Next 2Y17.15%
EPS Next 3Y16.19%
EPS Next 5Y29.63%
Revenue Next Year-31.91%
Revenue Next 2Y-15.04%
Revenue Next 3Y-7.13%
Revenue Next 5Y-3.71%

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
OSUR Yearly Revenue VS EstimatesOSUR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 100M 200M 300M 400M
OSUR Yearly EPS VS EstimatesOSUR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 0.5 -0.5

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for OSUR. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for OSUR. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
OSUR Price Earnings VS Forward Price EarningsOSUR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
OSUR Per share dataOSUR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4 5

4.3 Compensation for Growth

OSUR's earnings are expected to grow with 16.19% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y17.15%
EPS Next 3Y16.19%

More info and screens

0

5. Dividend

5.1 Amount

OSUR does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ORASURE TECHNOLOGIES INC

NASDAQ:OSUR (6/13/2025, 8:00:02 PM)

After market: 2.95 0 (0%)

2.95

+0.02 (+0.68%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)05-07 2025-05-07/amc
Earnings (Next)08-04 2025-08-04/amc
Inst Owners89.56%
Inst Owner Change-2.86%
Ins Owners4.71%
Ins Owner Change21.43%
Market Cap220.66M
Analysts78
Price Target4.59 (55.59%)
Short Float %3.12%
Short Ratio3.24
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-71.32%
Min EPS beat(2)-142.2%
Max EPS beat(2)-0.43%
EPS beat(4)2
Avg EPS beat(4)-13.01%
Min EPS beat(4)-142.2%
Max EPS beat(4)67.32%
EPS beat(8)5
Avg EPS beat(8)-13.93%
EPS beat(12)8
Avg EPS beat(12)199.37%
EPS beat(16)8
Avg EPS beat(16)98.7%
Revenue beat(2)1
Avg Revenue beat(2)0.27%
Min Revenue beat(2)-0.02%
Max Revenue beat(2)0.56%
Revenue beat(4)3
Avg Revenue beat(4)0.75%
Min Revenue beat(4)-0.02%
Max Revenue beat(4)2.18%
Revenue beat(8)7
Avg Revenue beat(8)6.63%
Revenue beat(12)11
Avg Revenue beat(12)11.17%
Revenue beat(16)14
Avg Revenue beat(16)9.75%
PT rev (1m)-10%
PT rev (3m)-10%
EPS NQ rev (1m)0%
EPS NQ rev (3m)5.88%
EPS NY rev (1m)0%
EPS NY rev (3m)-96.55%
Revenue NQ rev (1m)-1.61%
Revenue NQ rev (3m)-7.4%
Revenue NY rev (1m)-1.45%
Revenue NY rev (3m)-6.52%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.37
P/FCF N/A
P/OCF 244.36
P/B 0.56
P/tB 0.65
EV/EBITDA N/A
EPS(TTM)-0.42
EYN/A
EPS(NY)-0.16
Fwd EYN/A
FCF(TTM)-0.02
FCFYN/A
OCF(TTM)0.01
OCFY0.41%
SpS2.16
BVpS5.3
TBVpS4.53
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -6.98%
ROE -8.06%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 41.98%
FCFM N/A
ROA(3y)1.01%
ROA(5y)-1.05%
ROE(3y)0.93%
ROE(5y)-1.4%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.22%
GM growth 5Y-6.88%
F-Score5
Asset Turnover0.35
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 24.08%
Cap/Sales 1.63%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 12.34
Quick Ratio 10.94
Altman-Z 2.63
F-Score5
WACC9.04%
ROIC/WACCN/A
Cap/Depr(3y)167.19%
Cap/Depr(5y)244.45%
Cap/Sales(3y)7.03%
Cap/Sales(5y)11.7%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-191.3%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-320%
EPS Next Y-123.62%
EPS Next 2Y17.15%
EPS Next 3Y16.19%
EPS Next 5Y29.63%
Revenue 1Y (TTM)-46.94%
Revenue growth 3Y-7.36%
Revenue growth 5Y3.75%
Sales Q2Q%-44.71%
Revenue Next Year-31.91%
Revenue Next 2Y-15.04%
Revenue Next 3Y-7.13%
Revenue Next 5Y-3.71%
EBIT growth 1Y-342.51%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-89.45%
EBIT Next 3Y44.24%
EBIT Next 5Y25.91%
FCF growth 1Y93.03%
FCF growth 3YN/A
FCF growth 5Y117%
OCF growth 1Y116.72%
OCF growth 3YN/A
OCF growth 5Y22.81%